Vincent S. Stoll

3.1k citations

49 papers · 1.5k indexed · h-index 22

Co-authors: John S. Blanchard E.F. Pai Kent D. Stewart Hing L. Sham Dale J. Kempf Clarissa G. Jakob Clarence J. Maring Saul H. Rosenberg
Topics: HIV/AIDS drug development and treatment (10 papers)Enzyme Structure and Function (10 papers)Chemical Synthesis and Analysis (7 papers)
Cited by: Virology Organic Chemistry Hepatology
Journals: Journal of Biological Chemistry Nature Communications Blood
Partner nations: United States United Kingdom Canada

In The Last Decade

Vincent S. Stoll

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by Vincent S. Stoll

Since Specialization

Citations

This map shows the geographic impact of Vincent S. Stoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent S. Stoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent S. Stoll more than expected).

Fields of papers citing papers by Vincent S. Stoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent S. Stoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent S. Stoll. The network helps show where Vincent S. Stoll may publish in the future.

Co-authorship network of co-authors of Vincent S. Stoll

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent S. Stoll. A scholar is included among the top collaborators of Vincent S. Stoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent S. Stoll. Vincent S. Stoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complex of human Melanotransferrin and SC57.32 Fab fragment reveals novel interdomain arrangement with ferric N-lobe and open C-lobe 2021 ·Scientific Reports ·(unknown),Kenton L. Longenecker,Yiliang Liu,Bryan Faust,(unknown),Johannes Hampl,Vincent S. Stoll,Sandro Vivona	4
2	Structure of human DPEP3 in complex with the SC-003 antibody Fab fragment reveals basis for lack of dipeptidase activity 2020 ·Journal of Structural Biology ·(unknown),Kenton L. Longenecker,Patrick Koenig,(unknown),Johannes Hampl,Vincent S. Stoll,Sandro Vivona	6
3	Accelerating pharmaceutical structure-guided drug design: a successful model 2018 ·Drug Discovery Today ·Lisa J. Keefe,Vincent S. Stoll	6
4	Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety 2011 ·Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson,Charles A. Flentge,(unknown),Rolf Wagner,Clarence J. Maring,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,(unknown),Gennadiy Koev,David W. A. Beno,Kent D. Stewart,Vincent S. Stoll,Akhteruzzaman Molla,Dale J. Kempf	7
5	Design and synthesis of pyridine–pyrazolopyridine-based inhibitors of protein kinase B/Akt 2007 ·Bioorganic & Medicinal Chemistry ·Gui‐Dong Zhu,Jianchun Gong,Viraj B. Gandhi,Keith W. Woods,Yan Luo,Xuesong Liu,Ran Guan,Vered Klinghofer,Eric F. Johnson,Vincent S. Stoll,Mulugeta Mamo,Qun Li,Saul H. Rosenberg,Vincent L. Giranda	58
6	Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discovery 2007 ·Journal of Computer-Aided Molecular Design ·Kent D. Stewart,Kevin Steffy,(unknown),John E. Harlan,Vincent S. Stoll,Jeffrey R. Huth,Karl A. Walter,(unknown),Renaldo Mendoza,Jean M. Severin,Paul L. Richardson,Leo W. Barrett,Edmund D. Matayoshi,Kerry M. Swift,Stephen F. Betz,(unknown),Dale J. Kempf,Akhter Molla	4
7	Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity 2005 ·Bioorganic & Medicinal Chemistry Letters ·Qun Li,Tongmei Li,Keith W. Woods,Wen‐Zhen Gu,Jerry D. Cohen,Vincent S. Stoll,(unknown),Charles W. Hutchins,David J. Frost,Saul H. Rosenberg,Hing L. Sham	66
8	Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Qun Li,Keith W. Woods,Weibo Wang,Nan‐Horng Lin,Akiyo Claiborne,Wen‐Zhen Gu,Jerry D. Cohen,Vincent S. Stoll,Charles W. Hutchins,David J. Frost,Saul H. Rosenberg,Hing L. Sham	28
9	Oximinoarylsulfonamides as potent HIV protease inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Clinton M. Yeung,Larry L. Klein,Charles A. Flentge,John T. Randolph,Chen Zhao,(unknown),Tatyana Dekhtyar,Vincent S. Stoll,Dale J. Kempf	27
10	Structure‐based Optimization of MurF Inhibitors 2005 ·Chemical Biology & Drug Design ·(unknown),Kenton L. Longenecker,Elizabeth H. Fry,Clarissa G. Jakob,Alan S. Florjancic,(unknown),David D. Anderson,Curt S. Cooper,Tianyuan Zhang,Richard F. Clark,(unknown),(unknown),Jennifer McCall,Claude G. Lerner,Philip J. Hajduk,Bruce A. Beutel,Vincent S. Stoll	30
11	Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gary T. Wang,Sheldon Wang,Robert G. Gentles,Thomas J. Sowin,Clarence J. Maring,Dale J. Kempf,Warren M. Kati,Vincent S. Stoll,Kent D. Stewart,Graeme Laver	16
12	Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·Qun Li,Akiyo Claiborne,Tongmei Li,Lisa Hasvold,Vincent S. Stoll,Steven W. Muchmore,Clarissa G. Jakob,(unknown),Jerry D. Cohen,Charles W. Hutchins,David J. Frost,Saul H. Rosenberg,Hing L. Sham	21
13	Characterization of protein kinase A phosphorylation: multi-technique approach to phosphate mapping 2003 ·Analytical Biochemistry ·Jianwei Shen,Richard A. Smith,Vincent S. Stoll,Rohinton Edalji,Clarissa G. Jakob,Karl A. Walter,(unknown),(unknown),Diane M. Bartley,Angelo Gunasekera,Jianguo Yang,Thomas F. Holzman,Robert W. Johnson	9
14	Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure 2003 ·Archives of Biochemistry and Biophysics ·Yaya Liu,Vincent S. Stoll,Paul L. Richardson,Ayda Saldivar,Jeffrey L. Klaus,Akhteruzzaman Molla,William E. Kohlbrenner,Warren M. Kati	16
15	X-ray crystallographic structure of ABT-378 (Lopinavir) bound to HIV-1 protease 2002 ·Bioorganic & Medicinal Chemistry ·Vincent S. Stoll,Wenying Qin,Kent D. Stewart,Clarissa G. Jakob,Chulyong Park,K.A. Walter,Robert L. Simmer,Rosalind Helfrich,(unknown),James Kao,Dale J. Kempf,Hing L. Sham,Daniel W. Norbeck	75
16	Design, synthesis, and neuraminidase inhibitory activity of GS-4071 analogues that utilize a novel hydrophobic paradigm 2002 ·Bioorganic & Medicinal Chemistry Letters ·Stephen Hanessian,(unknown),Debra Montgomery,Vincent S. Stoll,Kent D. Stewart,Warren M. Kati,Clarence J. Maring,Dale J. Kempf,Charles W. Hutchins,W.G. Laver	15
17	Insights into substrate binding by D-2-ketoacid dehydrogenases from the structure of Lactobacillus pentosus D-lactate dehydrogenase 1996 ·Structure ·Vincent S. Stoll,Matthew S. Kimber,E.F. Pai	51
18	Chemical mechanism and rate-limiting steps in the reaction catalyzed by Streptococcus faecalis NADH peroxidase 1991 ·Biochemistry ·Vincent S. Stoll,John S. Blanchard	9
19	[4] Buffers: Principles and practice 1990 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Vincent S. Stoll,John S. Blanchard	203
20	Kinetic mechanism and nucleotide specificity of NADH peroxidase 1988 ·Archives of Biochemistry and Biophysics ·Vincent S. Stoll,John S. Blanchard	13

About Vincent S. Stoll

Vincent S. Stoll is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), Enzyme Structure and Function (10 papers) and Chemical Synthesis and Analysis (7 papers). The work is most often cited by research in Virology (87 citations), Organic Chemistry (449 citations) and Hepatology (108 citations). Vincent S. Stoll has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John S. Blanchard, E.F. Pai, Kent D. Stewart, Hing L. Sham, Dale J. Kempf, Clarissa G. Jakob, Clarence J. Maring, Saul H. Rosenberg, Warren M. Kati and Matthew S. Kimber. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact